Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

ClinicalTrials.gov ID: NCT02607930

Public ClinicalTrials.gov record NCT02607930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy of a fixed dose combination (FDC) containing bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus a FDC containing abacavir/dolutegravir/lamivudine (ABC/DTG/3TC) in HIV-1 infected, antiretroviral treatment naive-adults.

Study identification

NCT ID
NCT02607930
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
631 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 13, 2015 (Actual)
Primary completion
May 9, 2017 (Actual)
Completion
Jul 2, 2021 (Actual)
Last update posted
Mar 2, 2022

2015 – 2021

United States locations

U.S. sites
78
U.S. states
23
U.S. cities
60
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294-2050 —
Spectrum Medical Group Phoenix Arizona 85012 —
Pueblo Family Physicians Phoenix Arizona 85015 —
Kaiser Permanente Medical Center Los Angeles California 90027 —
Ruane Clinical Research Group, Inc. Los Angeles California 90036 —
Anthony Martin Mills MD A Medical Corporation, DBA Mills Clinical Research Los Angeles California 90069 —
Alameda Health System- Highland Hospital Oakland California 94602 —
University of California Davis Sacramento California 95817 —
Kaiser Permanente Medical Group Sacramento California 95825 —
La Playa Medical Group San Diego California 92103 —
Kaiser Permanente San Francisco California 94118 —
Kaiser Permanente San Leandro California 94577 —
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center Torrance California 90502 —
Apex Research Denver Colorado 80209 —
Whitman-Walker Institute Washington D.C. District of Columbia 20009 —
Providence Hospital - DC Washington D.C. District of Columbia 20017 —
Capital Medical Associates Washington D.C. District of Columbia 20036 —
Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Therafirst Medical Center Fort Lauderdale Florida 33308 —
Gary J. Richmond, M.D., P.A. Fort Lauderdale Florida 33316 —
Midway Immunology and Research Center Ft. Pierce Florida 34982 —
AHF Kinder Medical Group Miami Florida 33133 —
Not listed Miami Florida 33140 —
Orlando Immunology Center Orlando Florida 32803 —
AIDS Healthcare Foundation-Miami Beach Pensacola Florida 32504 —
St. Joseph's Comprehensive Research Institute Tampa Florida 33614 —
AIDS Research and Treatment Center of the Treasure Coast Vero Beach Florida 32960 —
Triple O Research Institute PA West Palm Beach Florida 33401 —
Emory University Atlanta Georgia 30308 —
Atlanta Infectious Disease Group PC Atlanta Georgia 30309 —
Aids Research Consortium of Atlanta Inc Atlanta Georgia 30312 —
Augusta University Augusta Georgia 30912 —
Infectious Disease Specialists of Atlanta Decatur Georgia 30033 —
Chatham County Health Department Savannah Georgia 31401 —
Indiana CTSI Clinical Research Center Indianapolis Indiana 46202 —
Louisiana State University Health Sciences Center New Orleans Louisiana 70112 —
Baystate Medical Center Springfield Massachusetts 01199 —
Be Well Medical Center Berkley Michigan 48072 —
Henry Ford Health System Detroit Michigan 48202 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
Kansas City CARE Clinic Kansas City Missouri 64111 —
Southampton Clinical Research Group, Inc. St Louis Missouri 63108 —
Southampton Healthcare Inc St Louis Missouri 63139 —
Prime healthcare services - St Michael's LLC d/b/a Saint Michael's medical center Newark New Jersey 07102 —
South Jersey Infectious Disease Somers Point New Jersey 08244 —
Not listed Santa Fe New Mexico 87505 —
Upstate Infectious Disease Associates Albany New York 12208 —
Evergreen Health Buffalo New York 14215 —
North Shore University Hospital-(Manhasset) Manhasset New York 11030 —
Bronx Care The Bronx New York 10457 —
Montefiore Medical Center The Bronx New York 10467-2490 —
Aids Research Consortium of Atlanta Inc Chapel Hill North Carolina 27514 —
ID Consultants PA Charlotte North Carolina 28209 —
Not listed Greensboro North Carolina 27401 —
East Carolina University Greenville North Carolina 27858-4354 —
Rosedale Infectious Diseases Huntersville North Carolina 28078 —
Wake Forest Baptist Medical Center - PPDS Winston-Salem North Carolina 27157-1042 —
Summa Health System Akron Ohio 44304 —
University of Cincinnati Cincinnati Ohio 45267 —
MetroHealth Research Institute Cleveland Ohio 44109 —
Ohio State University Medical Center Columbus Ohio 43210 —
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 —
Philadelphia FIGHT Philadelphia Pennsylvania 19107 —
Allegheny Health Network Pittsburgh Pennsylvania 15212 —
Medical University of South Carolina PPDS Columbia South Carolina 29203-6840 —
Central Texas Clinical Research Austin Texas 78705 —
Saint Hope Foundation Inc Bellaire Texas 77401 —
AIDS Arms Inc Dallas Texas 75215 —
UT Southwestern Clinical Trials Office Dallas Texas 75235 —
North Texas Infectious Diseases Consultants PA Dallas Texas 75246 —
Not listed Fort Worth Texas 76104 —
Therapeutic Concepts Houston Texas 77004 —
Gordon E Crofoot MD PA Houston Texas 77098 —
Research Access Network Houston Texas 77098 —
Diagnostic Clinic of Longview Center For Clinical Research (DCOL) Longview Texas 75605 —
Peter Shalit MD Seattle Washington 98104 —
Multicare Rockwood HIV Critical Care Clinic Spokane Washington 99204 —
The Medical College of Wisconsin, Inc. Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02607930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2022 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02607930 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →